THERAVANCE INC Filed by BAUPOST GROUP LLC/MA

Similar documents
UNITED THERAPEUTICS CORP Filed by SHUMWAY CAPITAL PARTNERS LLC

EATON CORP PLC Filed by WELLINGTON MANAGEMENT CO LLP

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

PURE BIOSCIENCE, INC. Filed by OKUNO DALE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G T100 (CUSIP Number)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934

ACCESS INTEGRATED TECHNOLOGIES INC

BRIDGEPOINT EDUCATION, INC. (Name of Issuer)

LEGACY RESERVES LP Filed by BROTHERS PRODUCTION COMPANY, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934*

ZYNGA INC Filed by CAPITAL RESEARCH GLOBAL INVESTORS

American Midstream Partners, LP (Name of Issuer)

Spark Therapeutics, Inc.

ShotSpotter, Inc. (Name of Issuer)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G (Rule 13d-102)

Common Stock, par value $0.01 per share (Title of Class of Securities)

OAKTREE CAPITAL GROUP, LLC Filed by JMB CAPITAL PARTNERS MASTER FUND L.P.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G (RULE 13d - 102)

Inventergy Global, Inc (Name of Issuer)

PRINCIPAL FINANCIAL GROUP INC Filed by CAPITAL RESEARCH GLOBAL INVESTORS

Alliqua BioMedical, Inc.

SECURITIES & EXCHANGE COMMISSION EDGAR FILING. Support.com, Inc. Form: SC 13G/A. Date Filed:

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

KINGSTONE COMPANIES, INC.

Realogy Holdings Corp.

ST JOE CO Filed by THIRD AVENUE MANAGEMENT LLC

SECURITIES AND EXCHANGE COMMISSION SCHEDULE 13G/A

AON PLC Filed by CAPITAL RESEARCH & MANAGEMENT CO

Everi Holdings Inc. (Name of Issuer)

LEGACY RESERVES LP Filed by MORIAH PROPERTIES, LTD.

Recro Pharma, Inc. (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. REVOLUTION LIGHTING TECHNOLOGIES (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

American Midstream Partners, LP (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G (RULE 13d - 102)

Silvercrest Asset Management Group Inc. (Name of Issuer)

MEDICAL TRANSCRIPTION BILLING, CORP Filed by OMNI MEDICAL BILLING SERVICES, LLC

SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)

XILINX INC Filed by VANGUARD GROUP INC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Algodon Wines & Luxury Development Group, Inc.

SECURITIES AND EXCHANGE COMMISSION Washington, DC SCHEDULE 13G (Rule 13d-102)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Signet Jewelers (Name of Issuer)

united StateS SeCuritieS and exchange COMMiSSiOn Washington, D.C SCHeDuLe 13g

CENTERPOINT ENERGY INC Filed by VANGUARD GROUP INC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A. Ecology & Environment, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

Securities and Exchange Commission. Washington, D.C Schedule 13G. Under the Securities Exchange Act of (Amendment No.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A. Rosehill Resources Inc. (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

Main Street Capital Corp.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment 2)*

WASTE MANAGEMENT INC Filed by VANGUARD GROUP INC

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No.

GROUPON, INC. Filed by KEYWELL BRADLEY A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. KLR Energy Acquisition Corp.

SECURITIES & EXCHANGE COMMISSION EDGAR FILING. HCI Group, Inc. Form: SC 13G/A. Date Filed:

SUNOPTA INC. Filed by GRUBER & MCBAINE CAPITAL MANAGEMENT LLC

KAYNE ANDERSON MIDSTREAM ENERGY FUND, INC. (Name of Issuer)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A Amendment No. 3. Under the Securities Exchange Act of 1934

ROCKWELL COLLINS INC Filed by VANGUARD GROUP INC

SECURITIES AND EXCHANGE COMMISSION Washington, D.C Schedule 13G. Under the Securities Exchange Act of 1934 (Amendment No.

SECURITIES AND EXCHANGE COMMISSION SCHEDULE 13G/A

NELNET INC Filed by CEDAR HILL CAPITAL PARTNERS, LLC

BARRETT BUSINESS SERVICES, INC. (Name of Issuer) Common Stock (Title of Class of Securities) (CUSIP Number)

LEAR CORP Filed by MERRILL LYNCH PIERCE FENNER & SMITH INC

Taubman Centers, Inc. (Name of Issuer)

SECURITIES AND EXCHANGE COMMISSION. Washington, D.C Schedule 13G. Under the Securities Exchange Act of (Amendment No.

HASBRO INC Filed by CAPITAL GROUP COMPANIES INC

<SEQUENCE>1 <FILENAME>cpst_sc13g.txt. SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G (Rule 13d-102)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G (Rule 13d-102)

STRAYER EDUCATION INC Filed by AXA FINANCIAL INC

Floor & Décor Holdings, Inc. (Name of Issuer)

GOPHER PROTOCOL INC. Filed by FLEMING STEPHEN M.

SECURITIES & EXCHANGE COMMISSION EDGAR FILING CEL SCI CORP. Form: SC 13G/A. Date Filed:

3M CO Filed by BLACKROCK INC.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A. Under the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Limbach Holdings, Inc (Name of Issuer)

Propetro Holding Corp. (Name of Issuer)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G (Rule 13d-102)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G (Rule 13d-102)

GLOBUS MEDICAL INC Filed by PAUL DAVID C

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G (Rule 13d-102)

Section 1: SC 13G/A (SC 13G/A)

FISERV INC Filed by BLACKROCK INC.

Deutsche Bank AG Taunusanlage 12, D Frankfurt am Main Federal Republic of Germany. Jeffrey A. Ruiz Vice President Telephone: (212)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

NICE SYSTEMS LTD Filed by PSAGOT INVESTMENT HOUSE LTD.

COMCAST CORP Filed by MICROSOFT CORP

1/11/19. Securities and Exchange Commission 450 Fifth Street NW Washington, DC RE: Schedule 13G Thermon Group Holdings, Inc As of 12/31/18

CASTLE BRANDS INC Filed by CAMULOS CAPITAL LP

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

VERISIGN INC/CA Filed by LONE PINE CAPITAL LLC

Transcription:

THERAVANCE INC Filed by BAUPOST GROUP LLC/MA FORM SC 13G/A (Amended Statement of Ownership) Filed 12/9/8 Address 91 GATEWAY BLVD SOUTH SAN FRANCISCO, CA 948 Telephone 65886 CIK 1814 Symbol THRX SIC Code 2834 - Pharmaceutical Preparations Industry Biotechnology & Drugs Sector Healthcare Fiscal Year 12/31 http://www.edgar-online.com Copyright 28, EDGAR Online, Inc. All Rights Reserved. Distribution and use of this document restricted under EDGAR Online, Inc. Terms of Use.

CUSIP NO. 88338T14 13G PAGE 1 OF 1 SECURITIES AND EXCHANGE COMMISSION Washington, DC 2549 SCHEDULE 13G (Rule 13d-12) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 1)* Theravance,Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 88338T14 (CUSIP Number) November 3, 28 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) --------------- * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes.)

CUSIP NO. 88338T14 13G PAGE 2 OF 1 ******************************************************************************* 1. NAME OF REPORTING PERSON, S.S. OR I.R.S. IDENTIFICATION NO.OF ABOVE PERSON The Baupost Group, L.L.C., 4-342144 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP * (a) (b) X 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION The Commonwealth of Massachusetts NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON: 5. WITH SOLE VOTING POWER 6. WITH SHARED VOTING POWER 7. WITH SOLE DISPOSITIVE POWER 8. WITH SHARED DISPOSITIVE POWER 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES * 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 15.39% 12. TYPE OF REPORTING PERSON * IA

CUSIP NO. 88338T14 13G PAGE 3 OF 1 ******************************************************************************* 1. NAME OF REPORTING PERSON, S.S. OR I.R.S. IDENTIFICATION NO.OF ABOVE PERSON SAK Corporation, 4-3334541 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP * (a) (b) X 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION The Commonwealth of Massachusetts NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON: 5. WITH SOLE VOTING POWER 6. WITH SHARED VOTING POWER 7. WITH SOLE DISPOSITIVE POWER 8. WITH SHARED DISPOSITIVE POWER 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES * 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 15.39% 12. TYPE OF REPORTING PERSON * HC

CUSIP NO. 88338T14 13G PAGE 4 OF 1 ******************************************************************************* 1. NAME OF REPORTING PERSON, S.S.OR I.R.S. IDENTIFICATION NO.OF ABOVE PERSON Seth A. Klarman 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP * (a) (b) X 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION United States of America NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON: 5. WITH SOLE VOTING POWER 6. WITH SHARED VOTING POWER 7. WITH SOLE DISPOSITIVE POWER 8. WITH SHARED DISPOSITIVE POWER 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES * 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 15.39% 12. TYPE OF REPORTING PERSON * HC

CUSIP NO. 88338T14 13G PAGE 5 OF 1 ******************************************************************************* Item 1 (a) Name of Issuer: Theravance, Inc 1(b) Address of Issuer's Principal Executive Offices: 91 Gateway Blvd, South San Francisco, CA 948 Item 2 (a) Name of Person Filing: (1) The Baupost Group, L.L.C. (2) SAK Corporation (3) Seth A. Klarman 2(b) Address of Principal Business Offices or, if none, Residence: (1) The Baupost Group, L.L.C. 1 St. James Avenue, Suite 17 Boston, Massachusetts 2116 (2) SAK Corporation 1 St. James Avenue, Suite 17 Boston, Massachusetts 2116 (3) Seth A. Klarman 1 St. James Avenue, Suite 17 Boston, Massachusetts 2116 2(c) Citizenship: (1) The Commonwealth of Massachusetts (2) The Commonwealth of Massachusetts (3) United States of America 2(d) Title of Class of Securities: Common Stock 2(e) CUSIP Number: 88338T14

CUSIP NO. 88338T14 13G PAGE 6 OF 1 Item 3 If this statement is filed pursuant to SS24.13d-1(b) or 24.13d-2(b) or (c), check whether the person filing is a: (a) [ ]Broker or Dealer registered under Section 15 of the Act (15 U.S.C. 78o). (b) [ ]Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ]Insurance Company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c). (d) [ ]Investment Company registered under Section 8 of the Investment Company Act of 194 (15 U.S.C. 8a-8). (e) [X]An investment advisor in accordance with S24.13d-1(b)(1)(ii)(E). (f) [ ]An employee benefit plan or endowment fund in accordance with S24.13d-1(b)(1)(ii)(F). (g) [X]A parent holding company or control person in accordance with S24.13d-1(b)(ii)(G). (h) [ ]A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813). (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 194 (15 U. S.C. 8a-3). (j) [ ]Group, in accordance with S24.13d-1(b)(1)(ii)(J). Item 4 Ownership: Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount Beneficially Owned: (as of November 3, 28) (1) The Baupost Group, L.L.C.: (2) SAK Corporation: (3) Seth A. Klarman:

CUSIP NO. 88338T14 13G PAGE 7 OF 1 (b) Percent of Class: (1) The Baupost Group, L.L.C.: 15.39% (2) SAK Corporation: 15.39% (3) Seth A. Klarman: 15.39% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote --- (ii) shared power to vote or to direct the vote (1) The Baupost Group, L.L.C.: (2) SAK Corporation: (3) Seth A. Klarman: (iii)sole power to dispose or to direct the disposition of --- (iv) shared power to dispose or to direct the disposition of (1) The Baupost Group, L.L.C.: (2) SAK Corporation: (3) Seth A. Klarman: Instruction: For computations regarding securities which represent a right to acquire an underlying security seess.24.13d-3(d)(1).

CUSIP NO. 88338T14 13G PAGE 8 OF 1 Item 5 Ownership of Five Percent or Less of a Class: If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ]. Instruction: Dissolution of a group requires a response to this item. Item 6 Ownership of More than Five Percent on behalf of Another Person: The Baupost Group, L.L.C. ("Baupost") is a registered investment adviser. SAK Corporation is the Manager of Baupost. Seth A. Klarman, as the sole Director of SAK Corporation and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13(d) of the securities beneficially owned by Baupost. Securities reported on this Schedule 13G as being beneficially owned by Baupost include securities purchased on behalf of various investment limited partnerships. Item 7 Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company: See attached Exhibit A Item 8 Identification and Classification of members of the Group: N/A Item 9 Notice of Dissolution of Group: N/A

CUSIP NO. 88338T14 13G PAGE 9 OF 1 Item 1 Certification: Signature By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. December 9, 28 Date THE BAUPOST GROUP, L.L.C. By: /s/ Seth A. Klarman Seth A. Klarman President SAK CORPORATION By: /s/ Seth A. Klarman Seth A. Klarman President SETH A. KLARMAN By: /s/ Seth A. Klarman Seth A. Klarman

CUSIP NO. 88338T14 13G PAGE 1 OF 1 - EXHIBIT A Item 3 & Item 7 (1) The Baupost Group, L.L.C. IA (2) SAK Corporation HC (3) Seth A. Klarman HC The Baupost Group, L.L.C. ("Baupost") is a registered investment adviser. SAK Corporation is the Manager of Baupost. Seth A. Klarman, as the sole Director of SAK Corporation and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13(d) of the securities beneficially owned by Baupost. Securities reported on this Schedule 13G as being beneficially owned by Baupost include securities purchased on behalf of various investment limited partnerships. Pursuant to Rule 13d-4, Seth A. Klarman and SAK Corporation declare that the filing of this Schedule 13G shall not be deemed an admission by either or both of them that they are, for the purposes of Sections 13(d) or 13(g) the beneficial owner of any securities covered by this Schedule 13G, and further state that neither of them have any power to vote or dispose of, or direct the voting or disposition of, or direct the voting or disposition of, any of the securities covered by this Schedule 13G.